A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...
Methods: Patients having an identifiable cause of peripheral neuropathy, except alcohol, were excluded from the study. Patients with evidence of vitamin B 12 deficiency or diabetes were also ...
Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...
Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...
Scientists have designed a groundbreaking painkiller that activates solely at chronic pain sites, offering targeted, ...